FLORHAM PARK, N.J., May 24, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback